IBB vs XLV: holdings overlap, shared companies and scores
As of September 11, 2026, IBB and XLV overlap 12.1% by weight. iShares Biotechnology ETF (IBB): U.S. biotechnology stocks. State Street Health Care Select Sector SPDR ETF (XLV): U.S. healthcare sector.
Updated September 11, 2026
How much do IBB and XLV overlap?
As of September 11, 2026, IBB and XLV overlap 12.1% by weight.
39% of IBB is already inside XLV.
12% of XLV is already inside IBB.
IBB holds 239 companies and XLV holds 59; 9 are in both.
Computed by ETF Copilot from both funds' holdings rather than quoted from a data provider, and rebuilt nightly.
How does ETF Copilot score IBB and XLV?
As of September 11, 2026, ETF Copilot scores IBB 3.1 out of 10 and XLV 5.5 out of 10.
They differ most on Growth: IBB 1.9 and XLV 7.9.
The five factor scores behind them are set out below, 0–10 and higher is better, ranked against every US equity ETF we track.
| Factor | IBB | XLV |
|---|---|---|
| Growth | 1.9 | 7.9 |
| Valuation | 3.5 | 3.5 |
| Risk | 4.2 | 7.4 |
| Quality | 3.4 | 4.7 |
| Return | 3.1 | 3.6 |
XLV is the cheaper of the two at 0.08% a year
As of September 11, 2026, IBB charges 0.44% a year, yields 0.46% and holds $10.7B in assets across 239 positions.
As of September 11, 2026, XLV charges 0.08% a year, yields 1.80% and holds $43.4B in assets across 59 positions.
| Measure | IBB | XLV |
|---|---|---|
| Expense ratio | 0.44% | 0.08% |
| Dividend yield | 0.46% | 1.80% |
| Assets under management | $10.7B | $43.4B |
| Holdings | 239 | 59 |
Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.
Where IBB and XLV trade against their own history
IBB trades at 22.7 times earnings, against its own median of 21.5, and is more expensive than 60% of its own 114 monthly readings since 2017.
XLV trades at 30.3 times earnings, against its own median of 24.7, and is more expensive than 87% of its own 114 monthly readings since 2017.
What moved IBB and XLV this week
IBB fell 5.1% in the week to September 11, 2026. The holdings that moved it most were Amgen (−15.0%), Vertex Pharmaceuticals (−7.6%) and Regeneron Pharmaceuticals (−7.3%); Roivant Sciences (+18.6%) pushed the other way.
XLV fell 4.6% in the week to September 11, 2026. The holdings that moved it most were Eli Lilly (−3.8%), Amgen (−15.0%) and Johnson & Johnson (−4.6%); HCA Healthcare (+4.3%) pushed the other way.
What do IBB and XLV each hold?
What's inside IBB: AI 1%.
48% of IBB is its ten largest holdings.
What's inside XLV: AI 0%.
61% of XLV is its ten largest holdings.
Compare with similar funds
Cite this
ETF Copilot, “IBB vs XLV holdings overlap and scores”, as of September 11, 2026.
https://etf-copilot.com/compare/ibb-vs-xlv
Register free to unlock IBB vs XLV prices and holdings on ETF Copilot.
Register free →